ROR-gamma-t inhibitors (Merck & Co)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameROR-gamma-t inhibitors (Merck & Co)
Drug Alias NameROR-gamma inhibitors (Lycera)ROR-gamma inhibitors (Merck & Co)Th17 modulators (Lycera)Th17 modulators (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma antagonistsInterleukin-17 modulators
TargetsNuclear receptor ROR-gammaInterleukin-17
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLycera Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLycera CorpMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A